Men's Health News

RSS

Combination of new prostate cancer drugs can extend life for men

Combing two new prostate cancer drugs could increase the number of men who respond to treatment and the length of time they benefit, research led by The Institute of Cancer Research (ICR) has shown.

2 May 2012

FDA clears ProUroCare’s new prostate mechanical imaging system

ProUroCare Medical Inc., provider of proprietary medical imaging products, announced today it has received clearance from the U.S. Food & Drug Administration (FDA) for its ProUroScan prostate mechanical imaging (PMI) system.

2 May 2012

Detrimental effect of tetracycline on male reproductive function, sperm viability of pseudoscorpions

In a paper published today in Nature's open access journal Scientific Reports, researchers at the University of Nevada, Reno report that male pseudoscorpions treated with the antibiotic tetracycline suffer significantly reduced sperm viability and pass this toxic effect on to their untreated sons. They suggest that a similar effect could occur in humans and other species.

30 Apr 2012

VIVUS receives FDA approval for Stendra to treat erectile dysfunction

The U.S. Food and Drug Administration today approved Stendra (avanafil), a new drug to treat erectile dysfunction.

30 Apr 2012

FDA approves VIVUS’ STENDRA for treatment of erectile dysfunction

VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved STENDRA (avanafil) tablets for the treatment of erectile dysfunction (ED), marking the first new prescription agent approved in nearly a decade for the condition that afflicts as many as 30 million men in the U.S.

30 Apr 2012

Berries taken at least once a week can preserve memory functions: Study

The study of more than 16,000 women taking part in the Nurses' Health Study involved following them up since 1980. Between 1995 and 2001, researchers also measured the mental function of women who were over 70 and had not had a stroke.

29 Apr 2012

FDA issues Complete Response Letter to Amgen’s sBLA for XGEVA

Amgen today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the supplemental Biologics License Application (sBLA) for XGEVA (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases.

27 Apr 2012

Poverty linked to HIV infection among heterosexuals living in inner-city neighborhoods

In a groundbreaking study published last year, scientists reported that effective treatment with HIV medications not only restores health and prolongs life in many HIV-infected patients, but also curtails transmission to sexual partners up to ninety-seven percent. However, a new study by UCSF scientists shows that lack of basic living needs severely undercuts these advances in impoverished men.

27 Apr 2012

Healthy emmetropic women have a wider pupil diameter than men

From an anatomical point of view, a normal, non-pathological eye is known as an emmetropic eye, and has been studied very little until now in comparison with myopic and hypermetropic eyes. The results show that healthy emmetropic women have a wider pupil diameter than men.

27 Apr 2012

Studies: Against best advice, docs continue unneeded prostate screenings

JAMA and another journal found that despite government recommendations, doctors continue to screen too many men for prostate cancer.

26 Apr 2012

Funding for HIV programs among MSM populations lacking, largely due to stigma

"Despite high prevalence rates of HIV among men who have sex with men (MSM), funding for HIV prevention, treatment and care consistently neglects these populations, often due to stigma and discrimination," Owen Ryan, deputy director of public policy at amfAR, the Foundation for AIDS Research, writes in this guest post in the Funders Concerned About AIDS blog.

26 Apr 2012

Robot assisted laparoscopic radical prostatectomy better than other surgical techniques

Outcomes from use of a robot to assist surgeons in removal of a cancerous prostate are at least as good, if not better, than the other two techniques used for a radical prostatectomy -- open or laparoscopic surgery -- according to a large meta analysis led by researchers at NewYork-Presbyterian/Weill Cornell.

26 Apr 2012

PLUS Diagnostics, MDxHealth partner to co-promote ConfirmMDx for Prostate Cancer

MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, and PLUS Diagnostics today announced that they have entered into an agreement to co-promote MDxHealth's ConfirmMDx for Prostate Cancer test in the United States.

26 Apr 2012

New test accurately detects aggressive prostate cancer

One in six men will be diagnosed with prostate cancer during his lifetime, the second leading cause of death among men in the United States. It's a serious problem and current diagnostic tests aren't very specific. But a research team at the University of Central Florida NanoScience Technology Center has found a more accurate test that not only determines whether a patient has prostate cancer, but also how aggressive it is.

26 Apr 2012

Rise of eating disorders among men and boys

There is an alarming rise of eating disorders among men and boys. Psychologist Deanne Jade, founder of the National Centre For Eating Disorders, says while the route into eating disorders may be different for boys and girls, the underlying causes are all the same.

25 Apr 2012

Prostate cancer screening recommendations not heeded by 44% men: Survey

81-year-old billionaire Warren Buffett was diagnosed with prostate cancer after having the finding initially detected through a screening blood test to measure a cancer marker called prostate specific antigen or PSA.

25 Apr 2012

Oregano ingredient could treat prostate cancer

Oregano, the common pizza and pasta seasoning herb, has long been known to possess a variety of beneficial health effects, but a new study by researchers at Long Island University (LIU) indicates that an ingredient of this spice could potentially be used to treat prostate cancer, the second leading cause of cancer death in American men.

25 Apr 2012

Study sheds light on how stress differently affects women’s hearts

Coronary artery disease continues to be a major cause of death in the U.S., killing hundreds of thousands of people per year. However, this disease burden isn't evenly divided between the sexes; significantly more men than women are diagnosed with coronary artery disease each year. The reasons behind this difference aren't well defined. Though some studies have shown that men's hearts become more constricted than women's during exercise, letting less blood flow through, women are more likely than men to have symptoms of heart trouble after emotional upsets.

25 Apr 2012

Robot-assisted surgery more common and successful in treating prostate cancer

Robot-assisted surgery is now both more common and far more successful than radical "open" surgery to treat prostate cancer in the United States, according to a new Henry Ford Hospital study published in the current issue of the medical journal European Urology.

24 Apr 2012

Liver may be the key to weight regulation: Study

A team of Australian researchers have found that the liver could hold the key to treating obesity. They found that the liver plays a major role in regulating weight by communicating with the brain. The study will be published in the Journal Diabetes.

23 Apr 2012